Urinary Tract Infections And Urinary Incontinence - Presentation Transcript
Urinary Tract Infections and Urinary Incontinence By Ana Corona, FNP-Student University of Phoenix January 2003 More presentations at: www.nurseana.com
Prevalence of UTIs
Urinary Tract Infection (UTI) is the most common bacterial infection affecting humans
UTI is a serious health problem affecting millions of people each year
Over 8 million Americans seek medical attention for urinary tract infections annually.
Women are especially susceptible: one in five women will have at least one urinary tract infection during her life .
Pathophysiology
The urinary system consists of the kidneys, ureters, bladder, and urethra.
The kidneys remove liquid waste from the blood in the form of urine
Keep a stable balance of salts & substances in the blood, and produce a hormone that aids the formation of RBCs.
Pathophysiology: continued
The ureters carry urine from the kidneys to the bladder located in the lower abdomen.
Urine is stored in the bladder and emptied through the urethra.
The ureters and bladder normally prevent urine from backing up toward the kidneys, and the flow of urine from the bladder helps wash bacteria out of the body
Normal urine is sterile.
It contains fluids, salts, and waste products.
It is free of bacteria, viruses, and fungi.
Pathophysiology: Routes of Infection
Three well recognized routes of infection:
Ascending Transurethral Infection : fecal microorganisms colonizing the periurethral area and enter the bladder via the urethra
Hematogenous : spread as in staphylococcal bacteremia or renal cortex resulting in abscess formation
Short female urethra allows bacteria quick access to the bladder.
Sexual intercourse forces bacteria into bladder
Presence of foreskin, fecal incontinence, and poor toilet habits promote colonization by the fecal bacteria and contribute to the higher prevalence of infection seen in uncircumcised infants, young sexually active men and elderly men with poor anal sphincter control
Pathophysiology: Hematogenous Spread
Hematogenous spread of bacteria, fungi, and mycobacteria from distant focus of infection may invade the kidney, bladder or prostate
Pathophysiology: Direct Extension
Direct extension of bacteria from the gut into the bladder may occur via a colovesical fistula secondary to diverticulitis or colon cancer, Crohn’s disease
Classification of Urinary Tract Infections
Lower UTI : cystitis, urethritis, prostatitis
Upper UTI : acute or chronic pyelonephritis, renal or perirenal abscess
Uncomplicated and Complicated lower or upper UTI
Classification of Urinary Tract Infections
Complicated Lower or Upper UTI:
Risk of renal damage, urosepsis, abscess formation
Due to
Presence of functional or anatomic abnormalities, obstruction, calculi/catheter/stent, pregnancy, hospitalization, immunosuppression, diabetes mellitus, sickle cell disease, analgesic/NSAID abuse
Classification of Urinary Tract Infections
Acute urethral syndrome : dysuria/frequency with less than 10/ 5 colonies/ml of urine
Asymptomatic bacteriuria : asymptomatic with more than 10/ 5 colonies of the same bacteria per ml of clean-catch mid-stream urine
Presenting Signs & Symptoms Uncomplicated lower UTI
Acute Bacterial Cystitis:
Dysuria
Frequency
Urgency
Nocturia
Voiding of small urine volumes
Incontinence
Suprapubic or pelvic pain
Associated Signs & Symptoms
Hematuria
Foul smelling cloudy urine
Men experience a fullness in the rectum
Fever
Flank tenderness
Acute pyelonephritis
Signs & Symptoms :
Flank or low back pain, chills, fever, sweats, nausea, vomiting, headache and malaise
Associated Signs & Symptoms :
May have symptoms of cystitis
Hematuria, dysuria, polyuria
Signs & Symptoms in the Elderly
Less obvious signs:
Loss of appetite or a change in eating habits.
The sudden onset of confusion
Urinary incontinence
Complicated UTI: S/S
Clinical manifestations can range from asymptomatic bacteriuria to a severe gram-negative sepsis with shock
Can also present with signs and symptoms of acute cystitis or acute pyelonephritis
Hospitalized patients who suddenly develop signs and symptoms of septic shock or urosepsis should be considered even in the absence of urinary symptoms, particularly after a recent instrumentation of catherization.
Physical Findings
Acute Cystitis:
Suprapubic tenderness and distension
Acute Pyelonephritis:
Fever 104 F
Abdominal distension, hypotonic bowel sounds, severe tenderness in lumbar region
Physical Examination
PE in men should include:
Inspection and palpation of the genitals for evidence of urethral discharge, meatal erythema, inflammation of the glans penis, penile lesions, enlarged or tender epididymis or testicle, and inguinal lymphadenopathy.
A rectal examination with palpation of the prostate gland should be a standard part of the PE in all men with UTI symptoms
Diagnostic studies:
Urinalysis "clean catch“ (midstream)
Urine Culture & Sensitivity
When an infection does not clear up with treatment and is traced to the same strain of bacteria further tests may be ordered:
Computed Tomography (CT)
Ultrasound
Intravenous Pyelogram (IVP)
Cystoscope
Diagnostics
Urinalysis test: urine is examined for white and red blood cells and bacteria.
Urine Culture & Sensitivity: bacteria are grown in a culture and tested against different antibiotics to see which drug best destroys the bacteria.
Some microbes, like Chlamydia and Mycoplasma, can be detected only with special bacterial cultures.
One of these infections are suspected when there are symptoms of a UTI and pus in the urine, but a standard culture fails to grow any bacteria.
Differential Diagnosis
Acute Bacterial Cystitis should be differentiated from vulvovaginitis caused by yeast, trichomoniasis species or bacterial infections
STDs involving the urethra and cervix such as those caused by C. trachomatis, N. Gonorrhoeae and herpes simplex virus.
Between 10% to 30% of women with STDs or other forms of vaginitis have frequency and dysuria
Clinical Decision Making: Differential Diagnosis
Vulvovaginitis : external dysuria, soreness of the vulva, malodorous vaginal discharge, pruritus and dyspareunia
Pyuria and hematuria is rare
Urine culture reveals less than 10/ 2 colonies/ml
Urethritis: caused by sexually transmitted pathogens- gradual onset of dysuria without other urinary symptoms, vaginal discharge or bleeding or lower abdominal pain.
Pyuria with urine culture showing less than 10/ 2 colonies/ml
No hematuria
Clinical Decision Making based on Laboratory Findings
Urine Dip Stick:
bacterial counts >10/ 5 Enterobacteriaceae/ml of urine with concomitant pyuria can be detected by this method
Microscopic examination of centrifuged urine can detect the presence of significant pyuria (>4 WBCs per high power field), hematuria (>4 RBCs per high-power field) or both.
This provides further support for the diagnosis of UTI
Clinical Decision Making based on Laboratory Findings
Leukocyte casts: strongly support the diagnosis of pyelonephritis
1 st a.m. Urine: presence of >1 bacterium per high-power field on a gram-stained film of uncentrifuged urine correlates with >10/ 5 bacterial colonies/ml in 90% of pts
Clinical Decision Making: Differential Diagnosis
Presence of pyuria does not differentiate upper from lower UTIs
Pyuria in the absence of bacteriuria should raise the possibility of renal tuberculosis or allergic interstitial nephritis
Postmenopausal Women: atrophic changes in mucosa of the vulvovagina and urethra caused by hormone deficiency may result in persistent or recurrent frequency and dysuria
Renal and genitourinary neoplasms need to be ruled out
Differential Diagnosis
Acute Pyelonephritis
Young female patient should be differentiated from:
Pelvic inflammatory disease
Appendicitis
Atopic pregnancy
Ruptured ovarian cyst
Etiology: Risk Factors
Any abnormality of the urinary tract that obstructs the flow of urine such as a kidney stone, sets the stage for an infection.
An enlarged prostate gland can slow the flow of urine - raising the risk of infection
A common source of infection is catheters, or tubes, placed in the bladder.
The elderly or those with nervous system disorders who lose bladder control, may need a catheter for life
Etiology: Risk Factors
People with diabetes have a higher risk of a UTI because of changes in the immune system.
Immunosuppressed patients are at risk of a urinary infection.
For many women, sexual intercourse seems to trigger an infection
Women who use a diaphragm are more likely to develop a UTI than women who use other forms of birth control.
Women whose partners use a condom with spermicidal foam also tend to have growth of E. coli bacteria in the vagina
Recurrent UTI infections
Nearly 20% of women who have a UTI will have another
30% of those will have yet another.
Of the last group, 80 percent will have recurrences.
Usually, the latest infection stems from a strain or type of bacteria that is different from the infection before it, indicating a separate infection.
Even when several UTIs in a row are due to E. coli, slight differences in the bacteria indicate distinct infections.
Uncomplicated UTIs TMP-SMZ or 1 st generation cephalosporin Staphylococcus saprophyticus Amoxicillin Enterococcus faecalis TMP-SMZ or 1 st generation cephalosporin Klebsiella pneumoniae Amoxicillin or TMP-SMZ Proteus mirabilis TMP-SMZ or 1 st generation cephalosporin Escherichia coli Antibacterial of Choice: Organisms Commonly Found:
Clinical signs and symptoms may not always be accurate for distinguishing between Upper and Lower UTIs
Distinction between them is best assessed by the response to treatment
Clinical Decision Making :
UTIs are treated with antibacterial drugs.
The choice of drug and length of treatment depend on the patient's history and the urine tests that identify the offending bacteria.
The sensitivity test is especially useful in helping to select the most effective drug.
Acute Uncomplicated Cystitis: Single Dose Treatment Single Dose
TMP-SMZ 320/1600 mg, 2 double strength tabs
Amoxicillin 3gm
Cephaloridine 2gm
Gentamicin 5 mg/kg
Doxycycline 300 mg
Young woman, first episode
Acute Uncomplicated Cystitis: Short Course Treatment Short course 3 to 5 days
Trimethoprim 100-200mg q 12 hrs
TMP-SMZ 160/800 mg q 12 hrs
Nitrofurantoin 100 mg q 8 or 6 hrs
Amoxicillin 250 mg q 8 hrs
Ciprofloxacin 250-500 mg q 12 hrs
Norfloxacin 400 mg q 12 hrs
Young woman, first episode
Acute Uncomplicated Cystitis: 7 to 10 days
Trimethoprim 100-200mg q 12 hrs
TMP-SMZ 160/800 mg q 12 hrs
Nitrofurantoin 100 mg q 8 or 6 hrs
Amoxicillin 250 mg q 8 hrs
Ciprofloxacin 250-500 mg q 12 hrs
Norfloxacin 400 mg q 12 hrs
Diabetes
Mellitus
Symptoms
>7 days
Age >65 yrs
Diaphragm
Acute Uncomplicated Cystitis 7 to 10 days
Trimethoprim 100-200mg q 12 hrs
TMP-SMZ 160/800 mg q 12 hrs
Ciprofloxacin 250-500 mg q 12 hrs
Norfloxacin 400 mg q 12 hrs
Young healthy man
Recurrent Cystitis Single dose or 3-5 days 3-5 days, then 1 yr of prophylaxis TX as 1 st episode in young woman TMP+SMZ, amoxicillin, Nitrofurantoin, ciprofloxacin or Norfloxacin, followed by low-dose antibiotic prophylaxis Reinfection: < 2 episodes/yr > 3 episodes/yr 14 days
TX based on sensitivity results
R/O renal stones,
Scars, cysts,
Chronic Bacterial
Prostatitis
Relapses
Recurrent Cystitis Topical estradiol cream+low-dose antibiotic prophylaxis Postmenopause Postcoital prophylaxis TMP+SMZ, Nitrofurantoin cephalexin; voiding after intercourse Temporally related to coitus
Acute Uncomplicated Pyelonephritis 14 days Parenteral: ceftriaxone, gentamicin+ampicillin, aztreonam, or TMP-SMZ until afebrile, then oral regimen Pregnancy 14 days; if relapse, 6 weeks Oral: TMP+SMZ, amoxicillin, ciprofloxacin, Norfloxacin Not very sick Very sick or septic 14 days; if relapse, 6 weeks Parenteral: TMP-SMZ, ciprofloxacin, ceftriaxone, or gentamicin+ampicillin until afebrile, then oral regimen
Symptomatic Complicated Upper UTI 2 – 3 week; if relapse, 6 weeks Oral: ciprofloxacin, Norfloxacin, or TMP-SMZ (if sensitive) Not very sick 2 – 3 week; if relapse, 6 weeks Parenteral: gentamicin+ampicillin, ceftriaxone, aztreonam, imipenem-cilastatin, ciprofloxacin, ticarcillin-clavulanate Very sick or septic
Patient Education
Teach proper hygiene: Women wipe from front to back to prevent bacteria around the anus from entering the vagina or urethra.
Take showers instead of tub baths
Encourage patient to increase fluid intake and avoid of bladder irritants such as caffeine, smoking and alcohol.
Recommend cranberry juice that may decrease bladder colonization
Encourage patient to urinate when he/she feels the need
Patient Education: Continue
Advise voiding before and after sex
Cleanse the genital area before and after sexual intercourse.
Recommend alternative methods of contraception for women using diaphragms if recurrent infections exist
Avoid using feminine hygiene sprays and scented douches, which may irritate the urethra.
Discuss the need to complete entire course of medication
Follow-up & Referrals
Follow-up:
Repeat U/C after completion of medication
Advise pt to return if s/s increase in severity or fail to improve after 3 days of therapy.
Consultation/Referral if:
Renal Calculi are suspected
Infection persists after two courses of appropriate treatment
If pyelonephritis is suspected
If patient has insulin dependent diabetes
When patient has existing renal disease
History of 3 UTIs in one year
Research
Research funded by the National Institutes of Health (NIH) suggests that one factor behind recurrent UTIs may be the ability of bacteria to attach to cells lining the urinary tract.
A recent NIH-funded study has also shown that women with recurrent UTIs tend to have certain blood types.
Some researchers speculate that women with these blood types are more prone to UTIs because the cells lining the vagina and urethra may allow bacteria to attach more easily.
Further research will show whether this association is sound and proves useful in identifying women at high risk for UTIs.
Research
Researchers at the University of Washington found that 2-week therapy with TMP/SMZ was as effective as 6 weeks of treatment with the same drug in women with kidney infections that did not involve an obstruction or nervous system disorder.
In such cases, kidney infections rarely lead to kidney damage or kidney failure unless they go untreated
Research: Vaccine Development
In the future, scientists may develop a vaccine that can prevent UTIs from coming back.
Researchers in different studies have found that children and women who tend to get UTIs repeatedly are likely to lack proteins called immunoglobulins, which fight infection.
Children and women who do not get UTIs are more likely to have normal levels of immunoglobulins in their genital and urinary tracts
Research: Vaccine Development Continued
Early tests indicate that a vaccine helps patients build up their own natural infection-fighting powers.
The dead bacteria in the vaccine do not spread like an infection; instead, they prompt the body to produce antibodies that can later fight against live organisms.
Researchers are testing injection and oral vaccines to see which works best.
Another method being considered for women is to apply the vaccine directly as a suppository in the vagina
Urinary Incontinence (UI)
UI is the involuntary loss of urine severe enough to result in social or hygienic consequences
It is a major clinical problem and a significant cause of disability and dependence
Affects an estimate of 13 million adults in the United States
10% to 20% women age 15 to 64 years
40% women >60 years
Urinary Incontinence:
It results in a loss of self-esteem and a decrease in ability to maintain an independent lifestyle
UI is one of the major causes of institutionalization of the elderly
1995 – cost of treatment $26 billion for patients over age 65 years
Relevant Pathophysiology: Process of Urination
In adults the process of urination involves voluntary and reflexive control of the bladder, urethra, detrusor muscle and urethral sphincter.
When bladder volume reaches approx 400-500cc, stretch receptors send nerve impulses to the spinal cord.
Nerve impulses leaving the cord then cause the bladder to contract and the sphincters to relax so that urination may take place
Urinary Incontinence occurs as a result of a disruption at any point in the process
Risk Factors for Urinary Incontinence include any of the following:
Birth defects
Childbirth
CHF
Constipation - Impaction
Decreased mobility
Diabetes Mellitus
Diuretic medication
Hormone imbalances in women
Infection/inflammation of the urinary tract, vagina, or prostate
Injury or trauma
Medication Effects
Menopause
Nerve disorders or injuries
Overactive bladder muscles
Pelvic radiation Thx
Pelvic surgery
Polyuria
Prostate enlargement
Psychological factors
Weakness of the bladder, muscles that support the bladder or
Sphincter muscles that surround the urethra
S/S: UI is a Symptom
UI is a symptom rather than a disease
It can be caused by
Anatomical
Physiological
pathological (genitourinary) factors
That may Affect the urinary tract as well as external (nongenitourinary) factors
Multiple and interacting factors often contribute to UI development especially in frail older patients
Further evaluation of upper tract obstruction or other pathology identified by ultrasound
Differential Diagnosis
Incontinence may be considered as fixed or transient
Transient incontinence usually has definable, sudden onset and often has a discrete cause
A simple Mneumonic summarizes the differential diagnosis of transient incontinence
Etiologies for Transient Urinary Incontinence: DIAPERS Mneumonic
D rugs : hypnotics, sedatives, anticholinergic agents, diuretics, adrenergic agents
D elirium : or altered mental status
I nfection
A trophy: of vagina or urethra
P sychologic: functional depression
E ndocrine: hyperglycemia or hypercalcemia
R estricted mobility
S tool impaction
Urge Incontinence
Strong desire to void without the ability to suppress the urinary loss
Results from overactivity of the detrusor resulting in uncontrollable bladder contractions
There is loss related to a particular activity of exposure and is the most common type of incontinence noted in elderly
Frequently complicates central disorders: Parkinson's, Alzheimer's, CVA and brain tumor
Also noted with bladder disorders: outlet obstruction, carcinoma in situ and infection
Stress Incontinence
Urinary loss with physical activity or sudden increases in abdominal pressure
A deficiency of the bladder outlet
Result from hypermobility of urethra and bladder neck in women or from intrinsic damage in either sex
Reflex Incontinence
Related to urge incontinence
Manifested by the precipitous loss of urine with no sense of urgency
Noted in patients with suprasacral spinal cord lesions
Overflow Incontinence
Caused by chronic retention of urine with small volumes being frequently voided
May result from detrusor hypocontractility: seen in Tabes Dorsalis, diabetes mellitus or Vitamin B12 deficiency
May also result from bladder outlet obstruction caused by prostatic or urethral pathology with subsequent bladder decompensation
Continuous Incontinence
Total and unabated leakage of urine unrelated to activity
Identified when a fistula of the urinary tract is present
The most common etiology for urinary tract fistula in woman is prior hysterectomy
Mixed Category of Incontinence
More than one type of incontinence may be present
Especially in the elderly
An adult male may have both overflow incontinence due to prostatic obstruction and neurogenic bladder dysfunction secondary to diabetic neuropathy or cerebrovascular insufficiency
Diagnosis & Management of Urinary Incontinence by Type
Retropubic suspension
Needle bladder neck suspension
Anterior vaginal repair
Sling procedures
Artificial sphincter
urethrolysis
Estrogen therapy
Phenylpropanolamine (hcl) (PPA)
Pseudo-ephedrine hcl
Imipramine (Tofranil-PM)
Provocative stress test
(Direct visualization)
Tests for bladder neck mobility
UPP or leak point pressure
Simple Multichannel CMG
Stress Incontinence Surgical Thx Drug Thx DX studies Type of UI
Diagnosis & Management of Urinary Incontinence by Type
Augmenta-tion intestino-cystoplasty or urinary diversion
Urge incontinence Surgical Thx Drug Thx Dx Studies Type of UTI
Diagnosis & Management of Urinary Incontinence by Type
Cutting suspending sutures from previous Endoscopic needle bladder neck suspension
Urethrolysis (remobilization of periurethral adhesions) with or without resuspension
Doxazosin mesylate (Cardura)
Terazoxin hcl (Hytrin)
Tamsulosin hydrochloride (Flomax)
Post void residual volume
Uroflowmetry
Voiding CMG with EMG
Cystourethroscopy
Videourodynamics
Overflow Incontinence Surgical Thx Drug Thx DX studies Type of UI
Diagnosis & Management of Urinary Incontinence by Type Urinary diversion
Dicyclomine hcl
L-Hyoscyamine (Levbid)
Oxybutin (Ditropan)
IV-urography
US
Cystography
Urethrography
Cystourethroscopy
Serial cystometro-gram
Urodynamic voiding flow Sphincter EMG
Urethral pressure profile studies
Neurogenic Bladder Surgical Thx Drug Thx DX studies Type of UI
Diagnosis & Management of Urinary Incontinence by Type
Therapy is directed toward identifying and treating the specific type of incontinence present
Excretory urography
Voiding Cystourethro-graphy
Retrograde urethrography
Cystoscopy
Cystometro-gram
Urethral pressure profile
Mixed incontinence Drug Therapy & Surgical Thx DX studies Type of UI
Diagnosis & Management of Urinary Incontinence by Type
Surgical excision of fistulous tract
Urinary diversion
Excretory urography
Voiding cystourethro-graphy
Vaginoscopy
Urethro-cystoscopy
Urinary fistulas Artificial sphincter Residual urine Total incontinence Artificial sphincter Post-prostatectomy Incontinence Surgical Thx Drug Thx DX studies Type of UI
Diagnosis & Management of Urinary Incontinence by Type psychotherapy
Alpha-adrenergic
Anticholinergic
Diagnosis can be established only after all other causes of Urinary Incontinence are ruled out Psychogenic incontinence Surgical Thx Drug Thx DX studies Type of UI
Treatment Options for Stress, Urge and Mixed Urinary Incontinence: continued
Neuromuscular Electrical Stimulation:
Electrical stimulation of the pudendal nerve causes contraction of the pelvic floor and periurethral muscles.
InterStim Continence Control Therapy:
involves electrical stimulation of the sacral nerves via a totally implantable system
Patient & Family Education
Avoidance of cigarette smoking
Teaching Pelvic Muscle Exercise to symptomatic and asymptomatic younger and older women and to men who undergo prostate surgery
Instruct in proper lifting techniques to avoid abdominal strain
Encourage Frequent voiding
Encourage the use of protective undergarments and bedcovers
Appropriate Referral and Follow-ups
The FNP should consider minimal invasive, nonsurgical therapies first for those with stress, urge, and mixed UI
These include behavioral therapies and judicious use of medications
Refer to specialists if further assessment is necessary or if appropriate treatments are unavailable
Research
Study Purpose: to determine if there was a difference in pelvic floor muscle strength and reports of incontinence between women involved in high impact athletics and women who were relatively sedentary
The subjects were nulliparous women age 18-25 divided into 2 groups:
Grp I consisted of 20 women athletes who exercised a maximum of 6 hours/wk
Grp II: 15 women who exercised 1 hr/wk
Methods: Pelvic floor muscle strength was measured using EMG biofeedback via surface electrodes
Results: the athletic group was found to have significantly stronger pelvic floor muscle strength, p=.025.
Research: continued
49% of the entire sample reported incontinence with daily activities.
No difference was found in pelvic floor strength in subjects who reported incontinence compared to subjects with no report of incontinence.
Conclusions: although athletes had stronger pelvic floor muscles, they had no less report of urinary incontinence.
Across the entire sample, those who reported incontinence did not have significantly weaker pelvic floor muscles than those with no report of incontinence
This study suggested that pelvic floor strength is often not a predictor of incontinence
1 comments
Comments 1 - 1 of 1 previous next Post a comment